1Hiorn L R,Swansbury G J,Mehta J,etal.Additional chromosome abnormalities confer worse prognosis in acute promyelocyticleukemia.Br J Hematol,1997,96:314～321
2Chou W C,Tang J L,Yao M,et al.Clinical and biological characteristics of acutepromyelocytic leukemia in taiwan:a high relapse rate in patients with high initial andpeak white blood cell counts during all-trans retinoic acid treatment,Leukemia,1997,11:921～928
3Schoch C,Haase D,Gudat H,et al.Fifty-one patients with acute myeloid leukemia andtranslocation t(8;21)(q22;q22):an additional deletion in 9q is an adverse prognosticfactor.Leukemia,1996,10:1288～1295
4Licht J D,Chomienne C,Goy A,et al.Clinical and molecular characterization of a raresyndrome of acute promyelocytic leukemia associated with translocation(11;17).Blood,1995,85:1083～1094
6Galieni P,Marotta G,Vessichelli F,et al.Variant t(1;15;17)(q23;q22;q23) in a caseof acute promyelocytic leukemia.Leukemia,1996,10:1658～1661
7Saitoh K,Miura I,Kobayashi Y,et al.A new variant transiocation of t(15;17) in apatient with acute promyelocytic leukemia (M3):t(15;19;17)(q22;p13;q12).CancerGenet Cytogenet 1998,102:15～18
8Yamamoto K,Hamaguchi H,Nagata K,et al.A new complex translocation(15;20;17)(q22;p13;q21) in acute promyelocytic leukemia.Cancer Genet Cytogenet 1998,101:89～94
9Chong Y Y,Wong G C,Lau L C,et al.Acute promyelocytic leukemia with a dicentricchromosome involving chromosomes 11,17,and 18.Cancer Genet Cytogenet,1998,105:69～73
10Grimwade D,Howe K,Langabeer S,et al.Establishing the presence of the t(15;17) insuspected acute promyelocytic leukemia:cytogenetic,molecular and PML immunofluorescenceassessment of patients entered into the M.R.C. ATRA trial.Br J Hematol,1996,94:557～573
收稿 1999-01-04
4ChouWC, Tang JL, Yao M, et al. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment. Leukemia, 1997, 11:921-928.
5Grimwade D, Howe K, Langabeer S, et al. Establishing the presence of the t ( 15 ; 17 ) in suspected acute promyelocytic leukemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M. R. C. ATRA trial. M. R. C. Adult Leukaemia Working Party. Br J Haematol, 1996,94:557- 573.
6Lee JJ, Cho D, Chung IJ, et al. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia. Am J Hematol,2003,73 : 149-153.
7Casasnovas RO, Slimane FK, Garand R, et al. Immunological classification of acute myeloblastic leukemia: relevance to patient outcome. Leukemia,2003,17:515-527.
